Average Co-Inventor Count = 6.44
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Newron Pharmaceuticals S.p.a. (11 from 40 patents)
11 patents:
1. 9603832 - Substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives and their use as sodium and/or calcium channel modulators
2. 9585869 - Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
3. 9474737 - Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
4. 9474738 - Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
5. 9474739 - Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
6. 9248116 - Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
7. 9051240 - Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
8. 8519000 - Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
9. 8470877 - 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
10. 8129427 - 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
11. 7855227 - 2-phenylethylamino derivatives as calcium and/or sodium channel modulators